175 related articles for article (PubMed ID: 28582340)
21. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
22. Yolk Sac Tumor of the Ovary: A Report of 150 Cases and Review of the Literature.
Young RH; Wong A; Stall JN
Am J Surg Pathol; 2022 Mar; 46(3):309-325. PubMed ID: 34469331
[TBL] [Abstract][Full Text] [Related]
23. Ovarian Sertoli-Leydig cell tumour with α-fetoprotein-producing intestinal glandular cells. Clinical case and short review of basic literature.
Strus M; Rajtar-Ciosek A; Jach R; Hankus J; Szczepański W
Pol J Pathol; 2019; 70(3):226-231. PubMed ID: 31820869
[TBL] [Abstract][Full Text] [Related]
24. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
[TBL] [Abstract][Full Text] [Related]
25. Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases.
Gagnon S; Têtu B; Silva EG; McCaughey WT
Mod Pathol; 1989 Jan; 2(1):63-7. PubMed ID: 2466289
[TBL] [Abstract][Full Text] [Related]
26. Ovarian Sertoli-Leydig cell tumor with retiform pattern.
Moyles K; Chan YF; Hamill J; Massey R
Pathology; 1995 Oct; 27(4):371-3. PubMed ID: 8771159
[TBL] [Abstract][Full Text] [Related]
27. Sertoli-Leydig cell tumor of the ovary with alpha-fetoprotein production.
Tetu B; Ordóñez NG; Silva EG
Arch Pathol Lab Med; 1986 Jan; 110(1):65-8. PubMed ID: 2416299
[TBL] [Abstract][Full Text] [Related]
28. Sertoli-Leydig cell tumor of ovary with heterologous element: a case report.
Kataria SP; Mishra K; Dev G; Tandon R
Indian J Pathol Microbiol; 2005 Oct; 48(4):493-5. PubMed ID: 16366107
[TBL] [Abstract][Full Text] [Related]
29. Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor.
Golbang P; Khan A; Scurry J; MacIsaac I; Planner R
Gynecol Oncol; 1997 Oct; 67(1):102-6. PubMed ID: 9345364
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
[TBL] [Abstract][Full Text] [Related]
31. SALL4 is a useful marker for pediatric yolk sac tumors.
Wu P; Luo R; Sun B; Zhao J; Xu Q; Feng S; Chen X; Wang C
Pediatr Surg Int; 2020 Jun; 36(6):727-734. PubMed ID: 32222813
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.
Young RH; Perez-Atayde AR; Scully RE
Am J Surg Pathol; 1984 Sep; 8(9):709-18. PubMed ID: 6206735
[TBL] [Abstract][Full Text] [Related]
33. Ovarian Sertoli-Leydig cell tumor, endometrioid-like yolk sac tumor, and Y-chromosomal material.
De Giorgi U; Turci D; Crisanti E; Cantù MG; Cappellini A; Marangolo M
Oncology; 2003; 64(4):370-3. PubMed ID: 12759534
[TBL] [Abstract][Full Text] [Related]
34. Ovarian Sertoli-Leydig cell tumor in a 9-month-old infant with special histologic pattern.
Shu H; Yang Xh; Gao AF
Fetal Pediatr Pathol; 2012 Dec; 31(6):388-93. PubMed ID: 22443217
[TBL] [Abstract][Full Text] [Related]
35. High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Shojaei H; Hong H; Redline RW
Mod Pathol; 2016 Oct; 29(10):1278-88. PubMed ID: 27443515
[TBL] [Abstract][Full Text] [Related]
36. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature.
Grove A; Vestergaard V
Ann Diagn Pathol; 2006 Oct; 10(5):288-93. PubMed ID: 16979522
[TBL] [Abstract][Full Text] [Related]
37. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
[TBL] [Abstract][Full Text] [Related]
38. Retiform pattern of Sertoli-Leydig cell tumor of the ovary in a 4-year-old girl.
Kawatra V; Mandal S; Khurana N; Aggarwal SK
J Obstet Gynaecol Res; 2009 Feb; 35(1):176-9. PubMed ID: 19215568
[TBL] [Abstract][Full Text] [Related]
39. Ovarian sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid sertoli-leydig cell tumors).
McCluggage WG; Young RH
Am J Surg Pathol; 2007 Apr; 31(4):592-7. PubMed ID: 17414107
[TBL] [Abstract][Full Text] [Related]
40. Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review.
Burnik Papler T; Frković Grazio S; Kobal B
J Ovarian Res; 2016 Jul; 9(1):46. PubMed ID: 27473538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
